San Antonio — Executives at Rapamycin Holdings believe a decades-old drug used to prevent organ transplant rejection could find a new use as a ...
News
- Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer
- Cristal Glangchai Releases Venture Girls
“They are just always making things and trying to sell things,” says Glangchai, who has a doctorate in biomedical engineering. “It's about having that ...
- Ultragenyx: 1Q Earnings Snapshot
The biotechnology company posted revenue of $10.7 million in the period, which did not meet Street forecasts. Ten analysts surveyed by Zacks ...
- Twin Cities vie for Army innovation headquarters
The Army will consider the quality and growth potential of local workforces in nine areas, including biomedical engineering, chemical engineering and ...
- Charles Steger, former Virginia Tech president, dies at 70
During his time as the university's 15th president, from 2000 to 2014, Virginia Tech increased its enrollment, raised more than $1 billion in private funding, formed a school of biomedical engineering, created a public-private school of medicine, and joined the Atlantic Coast Conference,…